|  Join

Education

Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By

170 Results

  • SMFM - Global Health

    Contains 2 Component(s)

    Speaker: Timothy Johnson At the completion of this lecture the viewer should understand: 1-The scope of the global problem with maternal mortality; 2-The strategic and opportunistic approaches to thinking about global health; 3-The current programs that are in place with support from majo universities int he United States and 4-The vision, requirements and application process for the SMFM's Queenan Fellowship

  • 3D / 4D Ultrasound

    Contains 2 Component(s)

    Speaker: Larry Platt The main objectives of this presentation are to: 1- Discuss the role of 3D/4D in evaluating the fetus; 2- Discuss its role in evaluating the fetus for facial abnormalities; 3- Discuss its role in the evaluation of the fetal skeleton; 4- Discuss various 3D modalities to help in the assessment of fetal malformations

  • Three-Vessel Trachea View in Cardiac Imaging

    Contains 2 Component(s)

    Speaker: Alfred Abuhamad At the end of this presentation, the viewer should: 1- Understand how to obtain the 3-vessel trachea view; 2- Understand the anatomic landmarks at the level of the 3-vessel trachea view; 3- Understand the key characteristics of a normal 3-vessel trachea view and; 4- Understand the importance of the 3-vessel trachea view in screening for congenital heart defects and what anomalies may be detected at the level of the 3-vessel trachea view

  • Complex Contraception

    Contains 2 Component(s)

    Speaker: Melissa Gilliam At the completion of this lecture, the viewer should : 1-Understand the importance of avoiding short interpregnancy intervals; 2-Understand the array of contraceptive options available for women and how to choose the ideal method; 3-Understand when to initiate methods in the post-partum period and; 4-Recognize the importance of high quality family planning

  • Ethnicity-Based Genetic Carrier Screening

    Contains 2 Component(s)

    Speaker: Jeff Kuller At the completion of this lecture the viewer should understand : 1-Which ethnic groups are at the highest risk for genetic disorders; 2-The genetic disorders to screen for (their pathophysiology, mode of testing, carrier frequency and prenatal diagnosis); 3-The most common hemoglobinopathies and how to screen for them and 4-ACOG's recommendations

  • Perinatal Risk Factors for Autism: Talking Points for the Obstetrician

    Contains 2 Component(s)

    Speaker: Erin Clark The main objectives of this presentation are to: 1-Define autism; 2-Review the epidemiologic data; 3-Discuss perinatal risk factors and 4-Become better equipped to counsel patients for autism risk factors

  • OB Pharmacology - Part 2

    Contains 2 Component(s)

    Speaker: Steve Caritis The main objectives of this presentation are to: 1-Discuss the determinants of placental transport; 2-Present teratogens, toxicants and other fetal effects; 3-Present the FDA rule on pregnancy and; 4-Present the mechanism and regulators of drug transfer in breast milk

  • OB Pharmacology

    Contains 2 Component(s)

    Speaker: Steve Caritis The main objectives of this presentation are to: 1-Present the scope of the problem of medication use in pregnancy; 2-Present the FDA risk classification in pregnancy; 3-Review pregnancy effects on drug absorption, distribution, metabolism and elimination and; 4-Discuss pharmacodynamics in pregnancy

  • Update On VTE In Pregnancy: CHEST Guidelines

    Contains 2 Component(s)

    Speaker: Andra James The main objectives of this presentation are to: 1-Present the guidelines for VTE prophylaxis in pregnancy; 2-Present the purpose and methodology of ACCP guidelines; 3-Discuss the recommendations for anticoagulant use in pregnancy and lactation and 4-Discuss the management of acute VTE and VTE thromboprophylaxis in high risk patients

  • Non-Invasive Prenatal Testing (NIPT)

    Contains 2 Component(s)

    Speaker: Mary Norton The main objectives of this presentation are to: 1-Explain the biology behind testing of cfDNA in maternal serum; 2-Describe the technologies employed to evaluate cfDNA and risk for fetal aneuploidy; 3-Discuss some of the biologic complexities of this technology and 4-Explain the differences between different aneuploidies and test outcome